SCYX (STOCKS)
SCYNEXIS, Inc.
$4.090000
-0.140000 (-3.31%)
Prev close: $4.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Angulo Gonzalez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $40.77M
- Employees
- 29
- P/E (TTM)
- -1.14
- P/B (TTM)
- 0.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-3.36 | $-1.01 | -2.3536 | -233.86% |
|
Dec 2025 (Q4)
|
$1.94 | $1.03 | +0.9028 | +87.35% |
|
Sep 2025 (Q3)
|
$-0.17 | $-0.20 | +0.0340 | +16.67% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.19 | +0.0538 | +27.76% |
Financial Statements
| Revenues | $20.34M |
| Nonoperating Income/Loss | -$114.00K |
| Operating Expenses | $44.75M |
| Selling, General, and Administrative Expenses | $15.26M |
| Research and Development | $29.49M |
| Operating Income/Loss | -$24.40M |
| Income/Loss From Continuing Operations After Tax | -$24.52M |
| Income/Loss From Continuing Operations Before Tax | -$24.52M |
| Net Income/Loss | -$24.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.52M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.48 |
| Diluted Earnings Per Share | -$0.48 |
| Basic Average Shares | 51,455,072 |
| Diluted Average Shares | 51,455,072 |
| Assets | $77.63M |
| Current Assets | $62.69M |
| Cash | $72.40M |
| Noncurrent Assets | $14.94M |
| Liabilities | $36.32M |
| Current Liabilities | $15.90M |
| Accounts Payable | $5.63M |
| Other Current Liabilities | $10.27M |
| Noncurrent Liabilities | $20.42M |
| Equity | $41.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $41.31M |
| Liabilities And Equity | $77.63M |
| Net Cash Flow From Operating Activities | -$5.92M |
| Net Cash Flow From Operating Activities, Continuing | -$5.92M |
| Net Cash Flow From Investing Activities | $11.34M |
| Net Cash Flow From Investing Activities, Continuing | $11.34M |
| Net Cash Flow From Financing Activities | $23.95M |
| Net Cash Flow From Financing Activities, Continuing | $23.95M |
| Net Cash Flow | $29.37M |
| Net Cash Flow, Continuing | $29.37M |
| Comprehensive Income/Loss | -$24.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.52M |
| Other Comprehensive Income/Loss | $0.00 |